HDAC9 and hemoglobin measurement: By analyzing RNA abundance of HDACs in the clinically well annotated cohort of HB patients enrolled in the JPLT-2 trial [9], we detected a substantial expression of all HDACs in normal liver as well HB samples, except for HDAC9 (Fig. 2a).